EOM Pharmaceutical Holdings News

ImmunoCellular Therapeutics Ltd | D: Filing D

Sep 12, 2022 16:02 ET

EOM Pharmaceutical Holdings | 4: Statement of changes in beneficial ownership of securities-Director Yu John S

Jun 8, 2018 16:07 ET

EOM Pharmaceutical Holdings | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(1.1%),Daniel B. Asher(1.1%), etc.

Feb 13, 2018 06:31 ET

EOM Pharmaceutical Holdings | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Empery Asset Management, LP(0.38%),Ryan M. Lane(0.38%), etc.

Jan 16, 2018 12:47 ET

EOM Pharmaceutical Holdings | SC 13G: Statement of acquisition of beneficial ownership by individuals

Jul 31, 2017 06:06 ET

EOM Pharmaceutical Holdings | SC 13G: Statement of acquisition of beneficial ownership by individuals-Empery Asset Management, LP(9.99%),Ryan M. Lane(9.99%), etc.

Jul 19, 2017 12:07 ET

EOM Pharmaceutical Holdings | 4: Statement of changes in beneficial ownership of securities-Director Gengos Andrew

Feb 13, 2017 16:04 ET

EOM Pharmaceutical Holdings | 4: Statement of changes in beneficial ownership of securities-Director Yu John S

Jun 21, 2016 16:35 ET

EOM Pharmaceutical Holdings | 4: Statement of changes in beneficial ownership of securities-Officer Titus Gary

Jun 21, 2016 16:34 ET

EOM Pharmaceutical Holdings | 4: Statement of changes in beneficial ownership of securities-Director Singhvi Rahul

Jun 21, 2016 16:34 ET

EOM Pharmaceutical Holdings | 4: Statement of changes in beneficial ownership of securities-Director SCHLOSSBERG MARK A

Jun 21, 2016 16:33 ET

EOM Pharmaceutical Holdings | 4: Statement of changes in beneficial ownership of securities-Director LAPOINTE ANTHONY GREGG

Jun 21, 2016 16:32 ET